- Home
- OXSQ vs SOPH Comparison
OXSQ vs SOPH Comparison
Compare OXSQ & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- SOPH
- Stock Information
- Founded
- OXSQ 2003
- SOPH 2011
- Country
- OXSQ United States
- SOPH Switzerland
- Employees
- OXSQ N/A
- SOPH N/A
- Industry
- OXSQ Blank Checks
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OXSQ Finance
- SOPH Health Care
- Exchange
- OXSQ Nasdaq
- SOPH Nasdaq
- Market Cap
- OXSQ 190.1M
- SOPH 206.6M
- IPO Year
- OXSQ N/A
- SOPH 2021
- Fundamental
- Price
- OXSQ $2.47
- SOPH $2.95
- Analyst Decision
- OXSQ
- SOPH Strong Buy
- Analyst Count
- OXSQ 0
- SOPH 2
- Target Price
- OXSQ N/A
- SOPH $6.50
- AVG Volume (30 Days)
- OXSQ 440.9K
- SOPH 26.8K
- Earning Date
- OXSQ 04-25-2025
- SOPH 05-06-2025
- Dividend Yield
- OXSQ 17.07%
- SOPH N/A
- EPS Growth
- OXSQ N/A
- SOPH N/A
- EPS
- OXSQ N/A
- SOPH N/A
- Revenue
- OXSQ $42,166,831.00
- SOPH $67,173,000.00
- Revenue This Year
- OXSQ $8.73
- SOPH $14.86
- Revenue Next Year
- OXSQ N/A
- SOPH $22.76
- P/E Ratio
- OXSQ N/A
- SOPH N/A
- Revenue Growth
- OXSQ N/A
- SOPH 4.66
- 52 Week Low
- OXSQ $2.28
- SOPH $2.58
- 52 Week High
- OXSQ $3.28
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- OXSQ 43.43
- SOPH 48.73
- Support Level
- OXSQ $2.44
- SOPH $2.90
- Resistance Level
- OXSQ $2.48
- SOPH $3.33
- Average True Range (ATR)
- OXSQ 0.05
- SOPH 0.20
- MACD
- OXSQ 0.00
- SOPH 0.01
- Stochastic Oscillator
- OXSQ 21.87
- SOPH 34.25
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.